SEC ownership of Dicerna Pharmaceuticals Inc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001399529.
- CIK
- 0001399529
- Location
- Lexington, MA
- Parsed ownership evidence
- 3/4/5
- Lead holder
- Anna Protopapas
- Latest evidence date
- 06 Jul 2021
Ownership snapshot
Top shareholders of Dicerna Pharmaceuticals Inc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Anna Protopapas |
3/4/5
Director
|
—
class O/S missing
|
$127,487
3,333 shares
|
— | 03 Jun 2021 |
| Regina M. Paglia |
3/4/5
Chief Human Resources Officer
|
—
mixed-class rows
|
$77,533
63,236 shares
mixed-class rows
|
— | 06 Jul 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 29 May 2025.
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Current reporting-owner rows connected to Dicerna Pharmaceuticals Inc. Open the relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Anna Protopapas | Director | $127,487 | Mixed | 03 Jun 2021 | ||
| Regina M. Paglia | Chief Human Resources Officer | $77,533 | Mixed | 06 Jul 2021 | ||
| Adam Koppel | Director | Mixed | 28 Dec 2021 | |||
| Marc D. Kozin | Director | Mixed | 28 Dec 2021 | |||
| Douglas Fambrough | Chief Executive Officer, Director | Mixed | 28 Dec 2021 | |||
| Cynthia Smith | Director | Mixed | 28 Dec 2021 | |||
| Stephen K. Doberstein | Director | Mixed | 28 Dec 2021 | |||
| Martin I. Freed | Director | Mixed | 28 Dec 2021 | |||
| Robert D. Ciappenelli | Chief Strategy Officer | Mixed | 28 Dec 2021 | |||
| Douglas W. Pagan | Chief Financial Officer | Mixed | 28 Dec 2021 | |||
| James B. Weissman | Chief Operating Officer & EVP | Mixed | 28 Dec 2021 | |||
| Stephen J. Hoffman | Director | Mixed | 28 Dec 2021 | |||
| J. Kevin Buchi | Director | Mixed | 28 Dec 2021 | |||
| Bob D. Brown | Chief Scientific Ofr., EVP R&D | Mixed | 28 Dec 2021 | |||
| Shreeram Aradhye | EVP & Chief Medical Officer | Mixed | 28 Dec 2021 | |||
| Ling Zeng | Chief Legal Officer & Sec'y | Mixed | 28 Dec 2021 | |||
| Patrick M. Gray | Director | Mixed | 28 Dec 2021 |
Recent Insider Transactions by Companies or Individuals for Dicerna Pharmaceuticals Inc
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||